Harvard Biosciene to Close Massachusetts Manufacturing Plant

Dow Jones01-30

By Freddy Sebastian

Harvard Bioscience plans to close a manufacturing facility in Massachusetts and move production to Minneapolis and Europe, affecting an undisclosed number of roles.

The plant will remain operational through this year and consolidation is expected to be completed by the fist quarter of 2027, the company said Thursday. Transition-related costs will result in a rise in incremental operating expenses this year and into the first half of next year.

Some operations will also be relocated to facilities in Germany, Sweden and the United Kingdom.

Shares were off by 1.2% to 53 cents each in after-hours trading Thursday. The stock has plunged 70% in the past year.

"As we have been able to take a deeper look at the business, concentrating our U.S. manufacturing and relocating certain operations to respective international facilities will better leverage the scale, capabilities, and expertise of our sites," Chief Executive John Duke said.

The company, which manufactures and sells goods to support drug development, expects the move to result in about $3 million in cost savings next year and $4 million overall once fully implemented. Those savings include reduced overhead, merchandise structuring and a targeted reconfiguration of its workforce across affected operations.

Write to Freddy Sebastian at freddy.sebastian@wsj.com

(END) Dow Jones Newswires

January 29, 2026 17:19 ET (22:19 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2607052806?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-30 06:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2607052806","market":"us","top_or_hot":-1,"title":"Harvard Biosciene to Close Massachusetts Manufacturing Plant","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Freddy Sebastian \n</p>\n<p>\n  Harvard Bioscience plans to close a manufacturing facility in Massachusetts and move production to Minneapolis and Europe, affecting an undisclosed number of roles. \n</p>\n<p>\n  The plant will remain operational through this year and consolidation is expected to be completed by the fist quarter of 2027, the company said Thursday. Transition-related costs will result in a rise in incremental operating expenses this year and into the first half of next year. \n</p>\n<p>\n  Some operations will also be relocated to facilities in Germany, Sweden and the United Kingdom. \n</p>\n<p>\n  Shares were off by 1.2% to 53 cents each in after-hours trading Thursday. The stock has plunged 70% in the past year. \n</p>\n<p>\n  \"As we have been able to take a deeper look at the business, concentrating our U.S. manufacturing and relocating certain operations to respective international facilities will better leverage the scale, capabilities, and expertise of our sites,\" Chief Executive John Duke said. \n</p>\n<p>\n  The company, which manufactures and sells goods to support drug development, expects the move to result in about $3 million in cost savings next year and $4 million overall once fully implemented. Those savings include reduced overhead, merchandise structuring and a targeted reconfiguration of its workforce across affected operations. \n</p>\n<p>\n  Write to Freddy Sebastian at freddy.sebastian@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 29, 2026 17:19 ET (22:19 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Harvard Biosciene to Close Massachusetts Manufacturing Plant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHarvard Biosciene to Close Massachusetts Manufacturing Plant\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-01-30 06:19</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Freddy Sebastian \n</p>\n<p>\n  Harvard Bioscience plans to close a manufacturing facility in Massachusetts and move production to Minneapolis and Europe, affecting an undisclosed number of roles. \n</p>\n<p>\n  The plant will remain operational through this year and consolidation is expected to be completed by the fist quarter of 2027, the company said Thursday. Transition-related costs will result in a rise in incremental operating expenses this year and into the first half of next year. \n</p>\n<p>\n  Some operations will also be relocated to facilities in Germany, Sweden and the United Kingdom. \n</p>\n<p>\n  Shares were off by 1.2% to 53 cents each in after-hours trading Thursday. The stock has plunged 70% in the past year. \n</p>\n<p>\n  \"As we have been able to take a deeper look at the business, concentrating our U.S. manufacturing and relocating certain operations to respective international facilities will better leverage the scale, capabilities, and expertise of our sites,\" Chief Executive John Duke said. \n</p>\n<p>\n  The company, which manufactures and sells goods to support drug development, expects the move to result in about $3 million in cost savings next year and $4 million overall once fully implemented. Those savings include reduced overhead, merchandise structuring and a targeted reconfiguration of its workforce across affected operations. \n</p>\n<p>\n  Write to Freddy Sebastian at freddy.sebastian@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 29, 2026 17:19 ET (22:19 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HBIO","symbol_name":"哈佛生物科学","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2607052806","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2607052806","pubTimestamp":1769725140,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Harvard Bioscience plans to close a manufacturing facility in Massachusetts and move production to Minneapolis and Europe, affecting an undisclosed number of roles.The plant will remain operational through this year and consolidation is expected to be completed by the fist quarter of 2027, the company said Thursday. Transition-related costs will result in a rise in incremental operating expenses this year and into the first half of next year.Some operations will also be relocated to facilities in Germany, Sweden and the United Kingdom.Shares were off by 1.2% to 53 cents each in after-hours trading Thursday. The stock has plunged 70% in the past year.\"As we have been able to take a deeper look at the business, concentrating our U.S. manufacturing and relocating certain operations to respective international facilities will better leverage the scale, capabilities, and expertise of our sites,\" Chief Executive John Duke said.The company, which manufactures and sells goods to support drug d","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HBIO":"哈佛生物科学","BK4121":"生命科学工具和服务"},"translate_title":"哈佛生物科学公司将关闭马萨诸塞州制造工厂","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HBIO":0.9},"content_text":"By Freddy Sebastian \n\n\n  Harvard Bioscience plans to close a manufacturing facility in Massachusetts and move production to Minneapolis and Europe, affecting an undisclosed number of roles. \n\n\n  The plant will remain operational through this year and consolidation is expected to be completed by the fist quarter of 2027, the company said Thursday. Transition-related costs will result in a rise in incremental operating expenses this year and into the first half of next year. \n\n\n  Some operations will also be relocated to facilities in Germany, Sweden and the United Kingdom. \n\n\n  Shares were off by 1.2% to 53 cents each in after-hours trading Thursday. The stock has plunged 70% in the past year. \n\n\n  \"As we have been able to take a deeper look at the business, concentrating our U.S. manufacturing and relocating certain operations to respective international facilities will better leverage the scale, capabilities, and expertise of our sites,\" Chief Executive John Duke said. \n\n\n  The company, which manufactures and sells goods to support drug development, expects the move to result in about $3 million in cost savings next year and $4 million overall once fully implemented. Those savings include reduced overhead, merchandise structuring and a targeted reconfiguration of its workforce across affected operations. \n\n\n  Write to Freddy Sebastian at freddy.sebastian@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 29, 2026 17:19 ET (22:19 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2607052806","isCrawlerRequest":true}